Fairmount Funds Management LLC sold APGE
January 22, 2026 · Form 4 insider transaction
Fairmount Funds Management LLC sold 1,750,000 shares of Apogee Therapeutics, Inc. at $76.30 per share, a transaction worth $133.53M. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 0 days after the transaction.
Direction
Disposed (sell-side)
Shares
1,750,000
Price
$76.30
Total value
$133.53M
Role—
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateJanuary 22, 2026
Filing dateJanuary 22, 2026
Shares owned after298,647
OwnershipIndirect
10b5-1 planNo
AmendedNo
Footnotes
Fairmount Funds Management LLC ("Fairmount") is the investment manager for Fairmount Healthcare Fund II L.P. The managers of Fairmount are Peter Harwin and Tomas Kiselak. Fairmount, Mr. Harwin, and Mr. Kiselak disclaim beneficial ownership of any of the reported securities, except to the extent of their pecuniary interest therein.